Brent Warner

2022

In 2022, Brent Warner earned a total compensation of $2.9M as President, Gene Therapy at Poseida Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$162,920
Option Awards$1,051,982
Salary$370,278
Stock Awards$1,052,953
Other$240,895
Total$2,879,028

Warner received $1.1M in stock awards, accounting for 37% of the total pay in 2022.

Warner also received $162.9K in non-equity incentive plan, $1.1M in option awards, $370.3K in salary and $240.9K in other compensation.

Rankings

In 2022, Brent Warner's compensation ranked 1,259th out of 5,733 executives tracked by ExecPay. In other words, Warner earned more than 78.0% of executives.

ClassificationRankingPercentile
All
1,259
out of 5,733
78th
Division
Manufacturing
617
out of 3,122
80th
Major group
Chemicals And Allied Products
228
out of 1,416
84th
Industry group
Drugs
207
out of 1,317
84th
Industry
Biological Products, Except Diagnostic Substances
49
out of 291
83rd
Source: SEC filing on April 26, 2023.

Warner's colleagues

We found three more compensation records of executives who worked with Brent Warner at Poseida Therapeutics in 2022.

2022

Mark Gergen

Poseida Therapeutics

Chief Executive Officer

2022

Eric Ostertag

Poseida Therapeutics

Chief Executive Officer

2022

Harry Leonhardt

Poseida Therapeutics

General Counsel

News

You may also like